我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

高血压病与炎症反应相关性的研究进展

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2013年第5期
页码:
606-608612
栏目:
综述
出版日期:
2013-09-25

文章信息/Info

Title:
Research progress of hypertension and inflammatory response
作者:
吴 婷1; 宗刚军2
（1.安徽医科大学无锡临床学院心内科，江苏 无锡 214044；2.中国人民解放军第101医院心血管内科，江苏 无锡 214044）
Author(s):
WU Ting1;  ZONG Gang jun2
(1.Department of Cardiology, Wuxi Clinical Hospital, Anhui Medical University, Wuxi 214044, Jiangsu, China; 2.Department of Cardiology, PLA 101 Hospital, Wuxi 210044, Jiangsu, China)
关键词:
高血压; 原发性; 炎症反应
Keywords:
hypertension;  inflammation;  therapy;  cytokines;  blood pressure
分类号:
R544.1
DOI:
-
文献标识码:
A
摘要:
越来越多的证据表明，炎症反应与原发性高血压病之间存在相关性。炎症因子会增加高血压病的患病率，并影响高血压病患者的诊断、治疗和预后。因此，采用一种新的治疗途径去干扰炎症反应和氧化应激可能会改善高血压患者的预后，延缓和减少血管并发症的发生。
Abstract:
Increasing evidence suggests that the inflammatory process is closely associated with essential hypertension. Inflammatory markers have been found to be associated with increased risk of hypertension and could be useful tools in the diagnosis of hypertension in the future. Data reviewed here provide evidence that identification of clinically useful indices and development of novel therapeutic approaches to interfering with inflammation and oxidative stress may ameliorate cardiovascular outcomes in hypertension.

参考文献/References

[1]MattaceRaso FU,Verwoert GC,Hofman A,et al.Inflammation and incidentisolated systolic hypertension in older adults: the Rotterdam study[J].J Hypertens,2010,28(5):892-895.
[2]Androulakis E,Tousoulis D,Papageorgiou N,et al.Essential hypertension: Is there a role for inflammatory mechanisms?[J].Cardiol Rev,2009,17(5):216-221.
[3]Braunersreuther V,Mach F,Steffens S.The specific role of chemokines in atherosclerosis[J].Thromb Haemost,2007,97(5):714-721.
[4]Rose P,Bond J,Tighe S,et al.Genes overexpressed in cerebral arteries following saltinduced hypertensive disease are regulated by angiotensin II, JunB, and CREB[J].Am J Physiol Heart Circ Physiol,2008,294(2):1075-1085.
[5]Brown NJ.Aldosterone and vascular inflammation[J].Hypertension,2008,51(2):161-167.
[6]Amiri F,Ko EA,Javeshghani D,et al.Deleterious combined effects of saltloading and endothelial cell restricted endothelin1 overexpression on blood pressure and vascular function in mice[J].J Hypertens,2010,28(6):1243-1251.
[7]Schulz E,Gori T,Münzel T.Oxidative stress and endothelial dysfunction in hypertension[J].Hypertens Res,2011,34(6):665-673.
[8]Touyz RM,Briones AM. Reactive oxygen species and vascular biology:implications in human hypertension[J].Hypertens Res,2011,34(1):5-14.
[9]Ienhuis HL,Westra J,Smit AJ,et al.AGE and their receptor RAGE in systemic autoimmune diseases:an inflammation propagating factor contributing to accelerated atherosclerosis[J].Autoimmunity,2009,42(4):302-304.
[10]Ao J,Shao Y,Lai W,et al.Association of polymorphisms in the RAGE gene with serum CRP levels and coronary artery disease in the Chinese Han population[J].J Hum Genet,2010,55(10):668-675.
[11]Tatasciore A,Zimarino M,Renda G,et al.Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension[J].Hypertens Res,2008,31(2):2137-2146.
[12]Kim KI,Lee JH,Chang HJ,et al.Association between blood pres sure variability and inflammatory marker in hypertensive patients[J].Circ J,2008,72(2):293-229.
[13]Abkin SW.The role of interleukin 18 in the pathogenesis of hypertensioninduced vascular disease[J].Nat Clin Pract Cardiovasc Med,2009,6(3):192-199.
[14]Chujo D,Yagi K,Asano A,et al.Telmisartan treatment decreases visceral fat accumulation and improves serum levels of adiponectin and vascular inflammation markers in Japanese hypertensive patients[J].Hypertens Res,2007,30(12):1205-1210.
[15]Onal IK,Altun B,Onal ED,et al.Serum levels of MMP-9 and TIMP-1 in primary hypertension and effect of antihypertensive treatment[J].Eur J Intern Med,2009,20(4):369-372.
[16]Rigsby CS,Ergul A,Portik Dobos V,et al.Effects of spironolactone on cerebral vessel structure in rats with sustained hypertension[J].Am J Hypertens,2011,24(6):708-715.
[17]Rosei EA,Morelli P,Rizzoni D,et al.Effects of nifedipine GITS 20 mg or enalapril 20 mg on blood pressure and inflammatory markers in patients with mildmoderate hypertension[J].Blood Press,2005,14(1):14-22.
[18]Takase A,Nakazawa A,Yamashita S,et al.Pioglitazone produces rapid and persistent reduction of vascular inflammation in patients with hypertension and type 2 diabetes mellitus who are receiving angiotensin II receptor blockers[J].Metabolism,2007,56(4):559-564.
[19]Edwardsa KM,Zieglerb MG,Millsa PJ.The potential antiinflammatory benefits of improving physical fitness in hypertension[J].J Hypertens,2007,25(8):1533-1542.

备注/Memo

备注/Memo:
收稿日期：2012-12-22.通讯作者：宗刚军，副主任医师，主要从事高血压病基础与临床研究 Email:zonggj@163.com 作者简介：吴婷，硕士生 Email:wutingdoctor@sina.com
更新日期/Last Update: 2013-09-30